𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of antiviral therapy for chronic hepatitis B: A disease in evolution

✍ Scribed by Sreekala Satheesh; Robert P. Perrillo

Book ID
107540408
Publisher
Current Science Inc.
Year
2005
Tongue
English
Weight
256 KB
Volume
4
Category
Article
ISSN
1540-3416

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum HBeAg quantitation during antivira
Serum HBeAg quantitation during antiviral therapy for chronic hepatitis B
✍ Heijtink, Rudolf A.; Kruining, Johannes; Honkoop, Pieter; Kuhns, Mary C.; Hop, W πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 92 KB πŸ‘ 2 views

Hepatitis Be antigen (HBeAg) seroconversion is considered the principal short-term goal of antiviral therapy in chronic hepatitis B. To test whether the pre-and per-treatment HBeAg quantitation has a higher predictive value than that of hepatitis B virus DNA (HBV-DNA) quantitation for the outcome of

Impact of disease severity on outcome of
Impact of disease severity on outcome of antiviral therapy in treatment-naΓ―ve patients with chronic hepatitis C
✍ Johan Westin; Kristoffer Hellstrand; Γ…sa AlsiΓΆ; Magdalena Ydreborg; Carlo Ferrar πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 113 KB

The results encourage a new HDV classification in which the Deltavirus genus consists of 8 major clades, 5 of them being present in Africa (i.e., clade 1, 5, 6, 7, and 8). 7 Interestingly, clade 5 isolates represent approximately 20% of HDV RNA-positive samples, which is stable for the time period i